ASCO GI 2023 Phase Ib OBERTO-201 Study: Evaluating Safety, Tolerability, Immunogenicity, & Efficacy of Multiple Subcutaneous Injections of PolyPEPI1018 Vaccine as an Add-On IO to TAS-102 in Late-Stage MSS mCRC

34 views
February 3, 2023
0 Comments
Login to view comments. Click here to Login